Investor Relations

MEDICLIN at a glance: Management Board, company profile, key data on business development and other important key data.

Annual General Meeting

Information and documents relating to Annual General Meeting.

Financial News and Financial Calendar

04November

2024

MEDICLIN increases consolidated sales and operating result - Management Board confirms annual forecast for 2024

31July

2024

MEDICLIN reports solid first half of 2024

10June

2024

Annual General Meeting of MEDICLIN AG approves all proposed resolutions

02May

2024

MEDICLIN increases consolidated sales and operating result in the first quarter of 2024

02May

2024

MEDICLIN: Transfer of operations of Reha-Klinik am Sendesaal to MEDICLIN took place on 1 May

05April

2024

MEDICLIN buys Reha-Klinik am Sendesaal

Financial Calendar

27. February 2025

Disclosure of the preliminary figures for the 2024 financial year

28. March 2025

Annual press and analysts’ conference for the 2024 financial year

02. May 2025

Publication of the interim report from 1 January 2025 to 31 March 2025

04. June 2025

Annual General Meeting

31. July 2025

Publication of the interim report from 1 January 2025 to 30 June 2025

04. November 2025

Publication of the interim report from 1 January 2025 to 30 September 2025

Corporate Governance

Our corporate governance report creates transparency about the corporate governance self-understanding of MEDICLIN.

Share price & charts

Track the price of the MEDICLIN-share on various stock exchanges in Germany.

Facts & Figures

Management Board, company profile, key data on business development and other important key data

Publications

Please download the current interim reports and annual reports and sustainability reports (only in German) as pdf.

Subcribte to MEDICLIN IR-Newsletter

MEDICLIN keeps you informed on a regular basis about latest IR-news. This service is available in German only.

Your Contacts

Ender Gülcan

Head of Investor Relations and Sustainability

MEDICLIN Unternehmenszentrale

Tel.: +49 781 488 326
Fax.: +49 781 488 184
Write message